In a 76‑year‑old man with atrial fibrillation on Xarelto (rivaroxaban), a history of alcohol use, presenting with fatigue, anorexia, weight loss, and a self‑limited nosebleed, who has isolated macrocytic anemia with normal vitamin B12, folate, liver enzymes, thyroid function, renal function, calcium, and fasting glucose, what are the differential diagnoses and the best next step in management?

Macrocytic Anemia in a 76-Year-Old Man on Rivaroxaban with Constitutional Symptoms

The best next step is to obtain a reticulocyte count and peripheral blood smear immediately, followed by bone marrow aspiration and biopsy with cytogenetics if myelodysplastic syndrome (MDS) is suspected—particularly given the patient's age, unexplained constitutional symptoms (fatigue, anorexia, weight loss), and macrocytic anemia despite normal B12/folate levels. 1

Differential Diagnoses

Most Likely: Myelodysplastic Syndrome

• MDS is the leading concern in this 76-year-old patient presenting with isolated macrocytic anemia, constitutional symptoms (fatigue, anorexia, weight loss), and normal vitamin B12/folate levels 2, 1
• The combination of advanced age, unexplained weight loss, and macrocytosis with normal nutritional studies strongly suggests a primary bone marrow disorder 3
• MDS typically presents with stable cytopenia and requires at least one decisive criterion: dysplasia ≥10% in one major bone marrow lineage, blast count 5-19%, or MDS-associated karyotype 2

Alcohol-Related Macrocytosis

• Chronic alcohol use directly causes macrocytosis through impaired DNA synthesis and can impair B12 absorption, even when serum B12 levels appear normal 1
• However, alcohol-related macrocytosis alone does not typically explain the constitutional symptoms or nosebleed 4

Medication Effect (Rivaroxaban)

• While rivaroxaban can cause bleeding complications, it does not directly cause macrocytic anemia 5, 6
• The nosebleed may be related to rivaroxaban, especially with concurrent alcohol use (which increases bleeding risk) 5

Occult Malignancy

• Weight loss, anorexia, and fatigue raise concern for underlying malignancy with bone marrow infiltration 1
• Bone marrow biopsy would identify infiltrative processes 2

Best Next Steps in Management

Immediate Laboratory Evaluation

• Obtain reticulocyte count to differentiate regenerative from non-regenerative anemia; a low/normal count points toward MDS, nutritional deficiency, or bone marrow failure 1, 3
• Review peripheral blood smear for dysplastic features, hypersegmented neutrophils, blast cells, or multilineage abnormalities 2, 1
• Complete blood count with differential to assess for pancytopenia (concurrent leukopenia or thrombocytopenia would strongly suggest MDS) 1
• Red cell distribution width (RDW) to identify coexisting iron deficiency, which can mask itself when combined with macrocytosis 1, 3

Additional Screening Tests

• Methylmalonic acid (MMA) level: If >271 nmol/L, this confirms functional B12 deficiency despite normal serum B12 1
• Serum erythropoietin level for prognostic information if MDS is confirmed 2
• Liver function tests to assess for occult liver disease related to alcohol use 1

Definitive Diagnostic Step

• Bone marrow aspiration and biopsy with cytogenetics is indicated when: 2, 1
  • Constitutional symptoms persist without clear cause
  • Reticulocyte count is low/normal with unexplained macrocytosis
  • Peripheral smear shows dysplastic features or cytopenias
  • MMA is normal (excluding functional B12 deficiency)
• Bone marrow evaluation should include: 2
  • Morphologic assessment for dysplasia in erythroid, granulocytic, and megakaryocytic lineages
  • Blast percentage determination
  • Prussian blue stain for ringed sideroblasts
  • Cytogenetic analysis (critical for MDS diagnosis and prognosis)
  • Flow cytometry to assess CD34+ cells and exclude PNH clone

Critical Management Considerations

Rivaroxaban and Bleeding Risk

• The self-limited nosebleed may represent a sentinel bleeding event on rivaroxaban 5, 6
• Modifiable bleeding risk factors in this patient include alcohol use (HR 2.37) and advanced age (HR 1.25 per 5-year increment) 5
• Consider holding rivaroxaban temporarily if invasive procedures (bone marrow biopsy) are planned, though the procedure can typically be performed safely with appropriate precautions 7, 8

Alcohol Cessation Counseling

• Alcohol cessation is essential, as it is both a modifiable bleeding risk factor and a potential contributor to macrocytosis 1, 5

Avoid Empiric Folate Supplementation

• Never initiate folate before excluding and treating B12 deficiency, as this can precipitate subacute combined degeneration of the spinal cord 1, 4
• Even though serum B12 is reported as normal, functional deficiency must be excluded with MMA testing 1

Common Pitfalls to Avoid

• Do not assume normal B12/folate levels exclude deficiency: Functional B12 deficiency can exist with normal serum levels; MMA testing is essential 1
• Do not attribute macrocytosis solely to alcohol without excluding MDS, especially with constitutional symptoms and advanced age 2, 3
• Do not delay bone marrow evaluation in elderly patients with unexplained cytopenias and constitutional symptoms, as early MDS diagnosis impacts prognosis and treatment options 2, 1
• Do not overlook coexisting iron deficiency: An elevated RDW may indicate mixed deficiency states that neutralize MCV 1, 3